The Use of Icosapent Ethyl on Vascular Progenitor Cells in Individuals With Elevated Cardiovascular Risk
Clinical trial NCT04562467 · COMPLETED
Trial details
- NCT number
- NCT04562467
- Sponsor
- Canadian Medical and Surgical Knowledge Translation Research Group
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-24
- Primary completion
- 2023-05-25
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.